Bloomios Reports Q2 2023 Financial Results
Bloomios Reports Q2 2023 Financial Results
Source: pr-inside.com
📰 Bloomios Private News
Bloomios Private News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bloomios Private. Real-time updates on events, politics, business and more.
Bloomios Appoints Kevin Henry as National Sales Director
SANTA BARBARA, Calif., June 9, 2023 /PRNewswire/ -- Bloomios, Inc. , a leading innovator in contract manufacturing of hemp-derived cannabinoid & mushroom edibles, cosmetic &... | June 9, 2023
Source: marketscreener.com
Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
Annualized Run Rate Hits $11.0 Million vs. $6.1 million in 2022, Driven by Increased Order Flow and Production Capacity Q2 2023 Outlook of Revenues to Exceed $3 million, up more than 137% SANTA... | June 1, 2023
Source: marketscreener.com
Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
/PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and...
Source: prnewswire.com
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
/PRNewswire/ -- Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived...
Source: prnewswire.com
Revere Securities acted as strategic advisor and placement agent for Bloomios Inc. for the $23.5M acquisition of a leading gummy manufacturer
/PRNewswire/ -- Revere Securities is pleased to announce the $23.5 Million acquisition of Infusionz, a wholly owned subsidiary of Upexi by Bloomios Inc....
Source: prnewswire.com
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
Transaction Expected to Double Production Capacity and Supports Entry of Direct-to-Consumer MarketSANTA BARBARA, Calif., Oct. 27, 2022 /PRNewswire...
Source: businessinsider.com
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
/PRNewswire/ -- Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived...
Source: prnewswire.com
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
Santa Barbara, California--(Newsfile Corp. - October 20, 2022) - Bloomios, Inc. (OTCQB: BLMS), a leading hemp derived cannabinoid supplements and nutraceutical contract manufacturer specializing in full
Source: finanznachrichten.de
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients
/PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading hemp and nutraceutical manufacturer specializing in full service product development, R&D and...
Source: prnewswire.com